BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34294706)

  • 1. Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3.
    Carabias A; Fuglsang A; Temperini P; Pape T; Sofos N; Stella S; Erlendsson S; Montoya G
    Nat Commun; 2021 Jul; 12(1):4476. PubMed ID: 34294706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
    Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
    Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage.
    Stella S; Alcón P; Montoya G
    Nature; 2017 Jun; 546(7659):559-563. PubMed ID: 28562584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanics of CRISPR-Cas12a and engineered variants on λ-DNA.
    Paul B; Chaubet L; Verver DE; Montoya G
    Nucleic Acids Res; 2022 May; 50(9):5208-5225. PubMed ID: 34951457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks.
    Cofsky JC; Karandur D; Huang CJ; Witte IP; Kuriyan J; Doudna JA
    Elife; 2020 Jun; 9():. PubMed ID: 32519675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miniature type V-F CRISPR-Cas nucleases enable targeted DNA modification in cells.
    Bigelyte G; Young JK; Karvelis T; Budre K; Zedaveinyte R; Djukanovic V; Van Ginkel E; Paulraj S; Gasior S; Jones S; Feigenbutz L; Clair GS; Barone P; Bohn J; Acharya A; Zastrow-Hayes G; Henkel-Heinecke S; Silanskas A; Seidel R; Siksnys V
    Nat Commun; 2021 Oct; 12(1):6191. PubMed ID: 34702830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4.
    Peng R; Li Z; Xu Y; He S; Peng Q; Wu LA; Wu Y; Qi J; Wang P; Shi Y; Gao GF
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):18928-18936. PubMed ID: 31467167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
    Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
    Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
    Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
    Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the miniature type V-F CRISPR-Cas effector enzyme.
    Takeda SN; Nakagawa R; Okazaki S; Hirano H; Kobayashi K; Kusakizako T; Nishizawa T; Yamashita K; Nishimasu H; Nureki O
    Mol Cell; 2021 Feb; 81(3):558-570.e3. PubMed ID: 33333018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for substrate recognition and cleavage by the dimerization-dependent CRISPR-Cas12f nuclease.
    Xiao R; Li Z; Wang S; Han R; Chang L
    Nucleic Acids Res; 2021 Apr; 49(7):4120-4128. PubMed ID: 33764415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into the R-loop formation and cleavage in CRISPR-Cas12i1.
    Zhang B; Luo D; Li Y; Perčulija V; Chen J; Lin J; Ye Y; Ouyang S
    Nat Commun; 2021 Jun; 12(1):3476. PubMed ID: 34108490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
    Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
    Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational Activation Promotes CRISPR-Cas12a Catalysis and Resetting of the Endonuclease Activity.
    Stella S; Mesa P; Thomsen J; Paul B; Alcón P; Jensen SB; Saligram B; Moses ME; Hatzakis NS; Montoya G
    Cell; 2018 Dec; 175(7):1856-1871.e21. PubMed ID: 30503205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mg
    Son H; Park J; Hwang I; Jung Y; Bae S; Lee S
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34853172
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ye Z; Moreb EA; Li S; Lebeau J; Menacho-Melgar R; Munson M; Lynch MD
    ACS Synth Biol; 2021 Jan; 10(1):29-37. PubMed ID: 33331764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.